| Autoimmune complications of immunotherapy: pathophysiology and management KK Chan, AR Bass bmj 369, 2020 | 108 | 2020 |
| Checkpoint inhibitor–associated arthritis: A systematic review of case reports and case series N Ghosh, MD Tiongson, C Stewart, KK Chan, B Jivanelli, L Cappelli, ... JCR: Journal of Clinical Rheumatology 27 (8), e317-e322, 2021 | 59 | 2021 |
| Eosinophilic fasciitis following checkpoint inhibitor therapy: four cases and a review of literature KK Chan, C Magro, A Shoushtari, C Rudin, V Rotemberg, A Rossi, ... The oncologist 25 (2), 140-149, 2020 | 51 | 2020 |
| Autoantibodies in patients with immune-related adverse events from checkpoint inhibitors: A systematic literature review N Ghosh, KK Chan, B Jivanelli, AR Bass JCR: Journal of Clinical Rheumatology 28 (2), e498-e505, 2022 | 44 | 2022 |
| Lower baseline autoantibody levels are associated with immune-related adverse events from immune checkpoint inhibition N Ghosh, M Postow, C Zhu, D Jannat-Khah, QZ Li, G Vitone, KK Chan, ... Journal for ImmunoTherapy of Cancer 10 (1), 2022 | 38 | 2022 |
| Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis AR Bass, N Abdel-Wahab, PD Reid, JA Sparks, C Calabrese, ... Annals of the rheumatic diseases 82 (7), 920-926, 2023 | 30 | 2023 |
| Clonally expanded CD38hi cytotoxic CD8 T cells define the T cell infiltrate in checkpoint inhibitor–associated arthritis R Wang, A Singaraju, KE Marks, L Shakib, G Dunlap, I Adejoorin, ... Science immunology 8 (85), eadd1591, 2023 | 22 | 2023 |
| Activated osteoarthritis following immune checkpoint inhibitor treatment: an observational study P Reid, DFL Liew, R Akruwala, AR Bass, KK Chan Journal for immunotherapy of cancer 9 (9), 2021 | 18 | 2021 |
| Higher checkpoint inhibitor arthritis disease activity may be associated with cancer progression: results from an observational registry KK Chan, A Tirpack, G Vitone, C Benson, J Nguyen, N Ghosh, ... ACR Open Rheumatology 2 (10), 595-604, 2020 | 17 | 2020 |
| Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor KK Chan, AR Bass Annals of the Rheumatic Diseases, annrheumdis-2018-213672, 2018 | 13 | 2018 |
| Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group N Ghosh, N Couette, WH van Binsbergen, SC Weinmann, B Jivanelli, ... Seminars in arthritis and rheumatism 58, 152110, 2023 | 11 | 2023 |
| Monitoring and management of the patient with immune checkpoint inhibitor-induced inflammatory arthritis: current perspectives KK Chan, AR Bass Journal of Inflammation Research, 3105-3118, 2022 | 8 | 2022 |
| Clonally expanded CD38hi cytotoxic CD8 T cells define the T cell infiltrate in checkpoint inhibitor-associated arthritis R Wang, A Singaraju, KE Marks, L Shakib, G Dunlap, ... ANNALS OF THE RHEUMATIC DISEASES 81, 457-457, 2022 | 3 | 2022 |
| High-dimensional Analyses of Checkpoint-inhibitor Related Arthritis Synovial Fluid Cells Reveal a Unique, Proliferating CD38hi Cytotoxic CD8 T Cell Population … R Wang, KK Chan, A Cunningham-Bussel, G Vitone, A Tirpack, C Benson, ... ARTHRITIS & RHEUMATOLOGY 72, 2020 | 3 | 2020 |
| Anticitrullinated peptide antibody epitope expansion and the HLA DRB1 ‘shared epitope’are less common in seropositive checkpoint inhibitor-induced inflammatory arthritis than … N Ghosh, P Reid, CA Aude, J Kirschman, S Goodman, VP Bykerk, ... RMD open 9 (2), e003012, 2023 | 2 | 2023 |
| Comparing the safety and effectiveness of methotrexate, TNF and IL6 inhibitors for the treatment of checkpoint inhibitor arthritis A Bass, N Abdel-Wahab, P Reid, J Sparks, C Calabrese, D Jannat-Khah, ... ARTHRITIS & RHEUMATOLOGY 74, 3322-3324, 2022 | 2 | 2022 |
| Pembrolizumab-induced phenotypic switch in psoriatic arthritis A Tirpack, KK Chan JCR: Journal of Clinical Rheumatology 27 (8S), S683-S684, 2021 | 2 | 2021 |
| Impact of COVID-19 on patients with rheumatic complications of cancer immunotherapy: results of a registry survey N Ghosh, A Tirpack, KK Chan, AR Bass Journal for Immunotherapy of Cancer 8 (2), 2020 | 1 | 2020 |
| AB1079 CHECKPOINT INHIBITOR-ASSOCIATED ARTHRITIS: PHENOTYPES AND CYTOKINE ASSOCIATIONS KK Chan, G Vitone, S Shanaj, A Tirpack, J Finik, L Donlin, D Rao, ... Annals of the Rheumatic Diseases 78 (Suppl 2), 2004-2005, 2019 | 1 | 2019 |
| Incidence of checkpoint inhibitor-associated inflammatory arthritis, immunomodulation and mortality in cancer patients on immunotherapy: a retrospective cohort study AR Bass, F Xie, D Jannat-Khah, N Ghosh, KK Chan, A Saxena, JR Curtis Rheumatology, keae343, 2024 | | 2024 |
